In Conversation

“ Regulatory conclusions reached in the past should never be assumed to apply indefinitely ”

“ Ultimately, success in rare disease launches comes down to flexibility and adaptability ”

“ Strong science matters, but intellectual property, execution, and strategy decide who ultimately wins ”

“ Population ageing is a formidable challenge, but the P4 framework – preventive, predictive, personalised, participatory – gives us a viable path forward ”

“ The more clinical trials we run locally, the more opportunities we have to introduce innovation earlier ”

“ The largest disconnect between approval and patient access is that much of the healthcare system is structurally designed to say “no.” ”

“ Taiwan is strategically important for supporting future launches and our 2030 vision ”

“ Sustaining innovation requires consistent investment in top scientific talent. When funding is this constrained, risk-taking and long-term discovery inevitably suffer ”

“ Credibility at this stage comes from doing fewer things well, not from doing many things quickly ”

“ If you address each of the scientific limitations directly, mRNA cancer vaccines can become a viable therapeutic class ”

“ Taiwan possesses leading-edge capabilities in semiconductors, AI manufacturing, and substantial healthcare data from universal coverage ”

“ We are not trying to be loud. We are focused on being reliable ”